House dust mites in pediatric atopic dermatitis

Saudi Medical Journal

Volumn 32, Issue 2, 2011, Pages 177-182

  Adham, Tamer M ^a,c   Tawfik, Safwat A ^b,c   Abdo, Naglaa M ^a  

^a Department of Pediatrics ^*

^b AIN SHAMS UNIVERSITY   (Egypt)

^c ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ACARICIDE; ANTIHISTAMINIC AGENT; HOUSE DUST ALLERGEN; MILBIOL; NEEM OIL; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ASSESSMENT; DERMATOPHAGOIDES; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; ECZEMA; ENVIRONMENTAL MANAGEMENT; ERYTHEMA; FEMALE; HOUSE DUST ALLERGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRESCHOOL CHILD; PRICK TEST; SCHOOL CHILD; SYMPTOM; TREATMENT OUTCOME; UNITED ARAB EMIRATES;

ACARICIDES; ANIMALS; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; ENVIRONMENT; FEMALE; HUMANS; MALE; SKIN TESTS; UNITED ARAB EMIRATES;

EID: 79951593091     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Barnetson RS, Rogers M. Childhood atopic eczema. BMJ 2002; 324: 1376-1379.
2. Sarkar R, Raj L, Kaur H, Basu S, Kanwar AJ, Jain RK. Psychological disturbances in Indian children with atopic eczema. J Dermatol 2004; 31: 448-454.
3. Al-Zoman AY, Al-Asmari AK. Pattern of skin diseases at Riyadh Military Hospital. Egyptian Dermatology Online Journal 2008; 4: 2.
4. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. ISAAC Lancet 1998; 351: 1225-1232.
5. Laughter D, Istvan JA, Tofte SJ, Hanifin JM. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 2000; 43: 649-655.
6. Bannister MJ, Freeman S. Adult-onset atopic dermatitis. Australas J Dermatol 2000; 41: 225-228.
7. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002; 46: 361-370.
8. Simpson A, Custovic A. The role of allergen avoidance in the secondary prevention of atopic disorders. Curr Opin Allergy Clin Immunol 2005; 5: 223-227.
9. The official list of allergens. Allergen nomenclature. [Accessed 2011 January 10; Updated 2010 April 29]. Available from: http://www.allergen.org
10. Platts-Mills TA, Vaughan JW, Carter MC, Woodfolk JA. The role of intervention in established allergy: avoidance of indoor allergens in the treatment of chronic allergic disease. J Allergy Clin Immunol 2000; 106: 787-804.
11. Adham TM, Tawfik SA, Abdo NM. Dermatophagoides pteronyssinus as a common allergen in the different subclasses of pediatric allergic rhinitis. Zagazig University Medical Journal 2008; 14: 2605-2610.
12. Ong PY, Leung DY. Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Res 2006; 6: 384-389.
13. Bousquet J. The allergic rhinitis and its impact on asthma (ARIA) workshop group. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108: 147-336.
14. Bussmann C, Böckenhoff A, Henke H, Werfel T, Novak N. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 2006; 118: 1292-1298.
15. Czarnecka-Operacz M, Silny W. Specific immunotherapy in atopic dermatitis--Four-year treatment in different age and airborne allergy type subgroups. Acta Dermatovenerol Croat 2006; 14: 230-240.
16. Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production. Clin Exp Allergy 2006; 36: 261-272.
17. Cadario G, Galluccio AG, Pezza M, Appino A, Milani M, Pecora S, et al. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study. Curr Med Res Opin 2007; 23: 2503-2506.
18. Bussmann C, Maintz L, Hart J, Allam JP, Vrtala S, Chen KW, et al. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy 2007; 37: 1277-1285.
19. Veitch GE, Beckmann E, Burke BJ, Boyer A, Maslen SL, Ley SV. Synthesis of azadirachtin: a long but successful journey. Angew Chem Int Ed Engl 2007; 46: 7629-7632.
20. Rembold H, Oetzel H. Study on the effectiveness of Milboil (neem oil formulation) against live mites, 1-year field test. Allergo Journal 2004; 13: 269-273.
21. Brenninkmeijer EE, Schram ME, Leeflang MM, Bos JD, Spuls PI. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol 2008; 158: 754-765.
22. Flohr C, Johansson SG, Wahlgren CF, Williams H. How atopic is atopic dermatitis? J Allergy Clin Immunol 2004; 114: 150-158.
23. Schmitt J, Langan S, Williams HC; European Dermato- Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Cl Immunol 2007; 120: 1389-1398.
24. Ong PY, Boguniewicz M. Atopic dermatitis. Prim Care 2008; 35: 105-117.
25. Werfel T, Kapp A. Atopic dermatitis and allergic contact dermatitis. In: Holgate ST, Church MK, Lichenstein LM, editors. Allergy. 2nd ed. London (UK): Mosby; 2001. p. 105-126.
26. Armitage P. Statistical methods in medical research. In: Armitage P, Mattews JNS, Berry G, editors. Scientific Publication. London (UK); Wiley-Blackwell; 2002. p. 109-191.
27. Janahi IA, Bener A, Bush A. Prevalence of Asthma among Qatari Schoolchildren. Pediatr Pulmonol 2005; 11: 163-168.
28. Ricci G, Patrizi A, Specchia F, Menna L, Bottau P, D'Angelo V, et al. Effect of house dust mite avoidance measures in children with atopic dermatitis. Br J Dermatol 2000; 143: 379-384.
29. Thomas WR, Smith WA, Hales BJ, Mills KL, O'Brien RM. Characterization and immunobiology of house dust mite allergens. Int Arch Allergy Immunol 2002; 129: 1-18.
30. Trombone AP, Tobias KR, Ferriani VP, Schuurman J, Aalberse RC, Smith AM, et al. Use of a chimeric ELISA to investigate immunoglobulin E antibody responses to Der p 1 and Der p 2 in mite-allergic patients with asthma, wheezing and/or rhinitis. Clin Exp Allergy 2002; 32: 1323-1328.
31. Erwin EA, Custis NJ, Satinover SM, Perzanowski MS, Woodfolk JA, Crane J, et al. Quantitative measurement of IgE antibodies to purified allergens using streptavidin linked to a high-capacity solid phase. J Allergy Clin Immunol 2005; 115: 1029-1035.
32. Mahesh PA, Kushalappa PA, Holla AD, Vedanthan PK. House dust mite sensitivity is a factor in chronic urticaria. Indian J Dermatol Venereol Leprol 2005; 71: 99-101.
33. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4: 1-191.
34. Durham SR, Church MK. Principles of allergy diagnosis. In: Holgate ST, Church MK, Lichenstein LM, editors. Allergy. 2nd ed. London (UK): Mosby; 2001. p. 3-16.
35. Räsänen L. Inhalant allergy in the United Arab Emirates. Allergy 2000; 55: 95-96.
36. Schäfer T, Borowski C, Reese I, Werfel T, Gieler U. German Network on Allergy Prevention Systematic review and evidencebased consensus guideline on prevention of allergy and atopic eczema of the German Network on Allergy Prevention (ABAP). Minerva Pediatr 2008; 60: 313-325.